-transparent.png){kind=logo}
We have previously reported that freshly isolated percoll-purified hepatocytes are MHC class I+, Class II- and stimulate allospecific cytotoxicity in mixed lymphocyte hepatocyte culture. In this report we determined the immunogenicity of purified hepatocytes in vivo using a modification of the sponge matrix allograft model. We found that hepatocytes were immunogenic in vivo because they stimulated the development of cytolytic effectors in allogeneic but not syngeneic hepatocyte sponge matrix allografts. These cytolytic effectors were not macrophages (because cytotoxicity was intact after nylon wool depletion of the bulk sponge effectors) but rather were Ly2+, L3T4- T cells. Cytolytic effectors in both MLHC and hepatocyte sponge matrix allografts demonstrated marked specificity for allogeneic MHC class I antigen of stimulator and donor hepatocytes, respectively. Allospecific cytolytic T cells developed in both MLHC and hepatocyte sponge matrix allografts across an isolated MHC class I genetic disparity but not across an isolated class II genetic disparity. Finally, sequential phenotypic analysis of host cells infiltrating allogeneic hepatocyte sponge matrix allografts demonstrated the presence of macrophages, Ly2+, L3T4- and Ly2-, L3T4+ T cells.
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
June 1997,
Transplantation proceedings,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
January 1970,
The Journal of experimental medicine,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
January 1979,
Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
January 1995,
Drugs under experimental and clinical research,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
January 1970,
Journal of immunology (Baltimore, Md. : 1950),
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
September 1994,
Carcinogenesis,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
May 1979,
Journal of immunology (Baltimore, Md. : 1950),
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
July 1993,
Clinical orthopaedics and related research,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
January 1985,
Journal of immunopharmacology,
G L Bumgardner, and
A J Matas, and
S Chen, and
D Cahill, and
T R Cunningham, and
W D Payne, and
F H Bach, and
N L Ascher
November 2000,
Nature medicine,
